Reports indicated that the facility will be initially extended to government hospitals and mohalla clinics At 1.04 pm, Dr Lal PathLabs Ltd (NSE: LALPATHLAB) share price quoted at Rs 2,363.70, down ...
Oct 23 (Reuters) - Dr. Lal PathLabs (DLPA.NS), opens new tab, India's top diagnostics firm by revenue, reported a bigger-than-expected second-quarter profit on Wednesday, driven by continued demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results